Most promisingly, perturbation of Met/SAM metabolism in either MLL-R cell line potently reduced global levels of H3K79me2, the DOT1L catalyzed activating modification absolutely required by MLL-R leukemia for survival and maintenance of malignant potential (Figure 2D). Here, KMT2A is linked to leukemia.